SCARDA: Japan’s Big Hope To Change Its Vaccine R&D Ecosystem
$1bn Support Now Expanded
Japan's SCARDA is building networks with academia and industry to support new vaccine development, while offering support through funding and knowledge. But is that enough to overcome the shortcomings highlighted by the pandemic?
